Form 4: Amgen SVP Rachna Khosla Reports Changes in Beneficial Ownership
SEC Form 4
Rachna Khosla, SVP of Business Development at Amgen, reports a transaction involving common stock on April 30, 2024, resulting in a beneficial ownership of 8,142 shares.
Summary
- On April 30, 2024, Rachna Khosla, a Senior Vice President at Amgen, reported a transaction involving Amgen's common stock.
- The transaction involved the disposal of 48 shares at a price of $276.38.
- Following the transaction, Khosla's beneficial ownership of Amgen common stock is 8,142 shares.
- These shares include Restricted Stock Units (RSUs) with various vesting schedules and Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: The document is a routine SEC Form 4 filing, indicating a change in beneficial ownership. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction involving common stock. |
| 05/05/2024 | 102 RSUs will vest. |
| 04/30/2025 | 128 RSUs will vest. |
| 11/05/2024 | 386 RSUs will vest. |
| 11/05/2025 | 398 RSUs will vest. |
| 05/02/2024 | 199 RSUs will vest. |
| 05/02/2025 | 200 RSUs will vest. |
| 05/02/2026 | 207 RSUs will vest. |
| 05/02/2025 | 195 RSUs will vest. |
| 05/02/2026 | 196 RSUs will vest. |
| 05/02/2027 | 202 RSUs will vest. |
| 05/02/2024 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.